Clinical Trial Update: NVT ALLEGRA TAVI System TF in Failing Calcified Aortic Heart Valves in a Real-world Patient Population

View source ↗

Summary

Clinical trial update for the NVT Allegra TAVI System TF in patients with failing calcified aortic valves; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• NVT Allegra TAVI System TF

Snippet

Sponsor: NVT GmbH | Conditions: Transcatheter Aortic Valve Implantation | Status: ACTIVE_NOT_RECRUITING